MRE11 and esophageal squamous cell carcinoma: MRE11A was highly expressed (mRNA z‐score ≥ 1.5) in about 4% (4 of 95) and reduced in 15% (z‐score ≤ −1.5) of ESCC patients (Fig. 1B).